Stock CAH CARDINAL HEALTH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Cardinal Health, Inc.

Equities

CAH

US14149Y1082

Real-time Estimate Cboe BZX
Other stock markets
 10:41:10 2024-05-14 am EDT 		5-day change 1st Jan Change
97.44 USD -0.61% Intraday chart for Cardinal Health, Inc. -2.12% -3.16%
May. 07 Cardinal Health Board of Directors Approves Increase to Quarterly Dividend, Payable on July 15, 2024 CI
May. 07 Deutsche Bank Adjusts Price Target on Cardinal Health to $110 From $116 MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Telix and Cardinal Health Complete Global Clinical Supply Agreement for Actinium-225 for Targeted Alpha Therapy Pipeline Development
AQ
Cardinal Health Board of Directors Approves Increase to Quarterly Dividend
PR
Cardinal Health Board of Directors Approves Increase to Quarterly Dividend, Payable on July 15, 2024
CI
Deutsche Bank Adjusts Price Target on Cardinal Health to $110 From $116
MT
Jefferies Cuts Cardinal Health's Price Target to $105 From $110
MT
Wells Fargo Raises Cardinal Health's Price Target to $95 From $94
MT
Baird Adjusts Price Target on Cardinal Health to $128 From $134
MT
Leerink Partners Adjusts Cardinal Health Price Target to $120 From $118
MT
Cardinal Health : Third Quarter 2024 Press Release
PU
Transcript : Cardinal Health, Inc., Q3 2024 Earnings Call, May 02, 2024
Cardinal Health Posts Higher Fiscal Q3 Non-GAAP Earnings, Revenue; Raises Fiscal 2024 Earnings Guidance
MT
Earnings Flash (CAH) CARDINAL HEALTH Reports Q3 Revenue $54.91B, vs. Street Est of $56.11B
MT
Earnings Flash (CAH) CARDINAL HEALTH Posts Q3 EPS $2.08, vs. Street Est of $1.95
MT
Cardinal: Fiscal Q3 Earnings Snapshot
AQ
Cardinal Health, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024
CI
Cardinal Health Reports Third Quarter Fiscal Year 2024 Results and Raises Fiscal Year 2024 Non-GAAP EPS Guidance
PR
Cardinal Health, Inc. Reports Impairment Charges for the Third Quarter Ended March 31, 2024
CI
Futures climb as Fed allays rate-hike worries
RE
Wells Fargo Adjusts Cardinal Health Price Target to $94 From $96
MT
US FDA sends warning to Cardinal Health for marketing unapproved devices
RE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CAH Stock
  4. News Cardinal Health, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW